Compare BioNTech SE - ADR (BNTX) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.21. The key difference: BioNTech SE - ADR is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| BNTX | USIG | |
|---|---|---|
Market Cap | $23.31B | — |
Sector | Health | Fixed Income |
52-Week High | $119.34 | $52.69 |
52-Week Low | $83.89 | $50.18 |
Enterprise Value | $6.60B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
